Findings from a posthoc analysis of 2 phase 3 trials suggest seladelpar monotherapy has similar safety and efficacy to seladelpar combined with UDCA.
Stuart Gordon, MD
Advertisement
Stuart Gordon, MD, is a professor of medicine at Wayne State University School of Medicine and director of the division of hepatology at Henry Ford Hospital.
Articles by Stuart Gordon, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
GLP-1 Initiation Associated With Increase in Hypotensive Events in Patients With Hypertension
2
Weight Loss Improves Cardiometabolic Biomarkers in Digital Metabolic Reset Program
3
GLP-1 RAs Show Renal, Survival Benefits in Kidney Transplant Recipients With Type 2 Diabetes
4
Diabetes Increases Mortality Risk Across All Major Organ Transplants
5